In ovarian cancer, researchers found that knockdown of BRD4 could significantly decrease Notch3 expression, and a chromatin immunoprecipitation test revealed that BRD4 existed in the promoter of Notch3 [34]. This evidence concerns the gene NOTCH3 and ovarian cancer.